For his dedication to achieving impact through commercialization, Stephen Badylak has been selected as the 2018 recipient of the Marlin Mickle Outstanding Innovator Award from the Innovation Institute. He is a professor of surgery at Pitt and deputy director of the McGowan Institute for Regenerative Medicine.
In his prolific 15 years at Pitt he ranks among the University’s all-time leaders in terms of invention disclosures filed, patents issued and technologies licensed. Earlier this year, Badylak became chief scientific officer of ECM Therapeutics, a new Pittsburgh-based startup company that has licensed a patent portfolio from Badylak’s lab and is seeking to commercialize those discoveries across a broad range of therapeutic targets.
More information can be found at the Innovation Institute’s website.